Search Results

You are looking at 131 - 140 of 251 items for :

  • "Acute myeloid leukemia" x
  • Refine by Access: All x
Clear All
Full access

NCCN News

members discussed treatment approaches in chronic myelogenous leukemia (CML) and acute myeloid leukemia (AML), and a panel of experts presented and deliberated challenging patient case studies. On Saturday, 12 sessions included patient cases in a variety

Full access

NCCN News

myeloid leukemia. A precongress program, the NCCN Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies will take place on Friday, September 21. This program provides hematology/oncology nurses with comprehensive information for

Full access

NCCN News

Solove Research Institute, Genomic Stratification and Prognostication of Adult Acute Myeloid Leukemia by Combination Mutation Status Roisin Connolly, MB, BCh, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Harnessing the Immune System

Full access

Who Benefits From Maintenance Therapy in Acute Promyelocytic Leukemia?

Edmond Marzbani and Elihu Estey

Acute promyelocytic leukemia (APL) is a rare subtype of acute myeloid leukemia (AML) accounting for 10% of the 13,400 adults diagnosed with AML in the United States. 1 The initial report by Hillestad 2 in 1957 described it as a disease marked by

Full access

Part I: The Role of Maintenance Therapy in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Philip L. McCarthy

maintenance, but further analysis is necessary to clarify these differences. MM and monoclonal gammopathy of unknown significance (MGUS) have both been associated with the development of acute myeloid leukemia/myelodysplastic syndromes. 41 Patients with

Full access

Care and Outcomes of Patients With Cancer Admitted to the Hospital on Weekends and Holidays: A Retrospective Cohort Study

Lauren Lapointe-Shaw, Hani Abushomar, Xi-Kuan Chen, Katerina Gapanenko, Chelsea Taylor, Monika K. Krzyzanowska, and Chaim M. Bell

overall risk of mortality, patients with cancer may be especially vulnerable to changes in care occurring on the weekend. 17 Patients admitted to the hospital for induction chemotherapy after a diagnosis of acute myeloid leukemia were reported to have a

Full access

The Utility of Routine Chest Radiography in the Initial Evaluation of Adult Patients With Febrile Neutropenia Patients Undergoing HSCT

Deborah S. Yolin-Raley, Ibiayi Dagogo-Jack, Heidi B. Niell, Robert J. Soiffer, Joseph H. Antin, Edwin P. Alyea III, and Brett E. Glotzbecker

, and the median age was 61 years (range, 21–77 years). Of the 269 patients admitted for allogeneic HSCT, 121 had acute myeloid leukemia, 49 had acute lymphoblastic leukemia, and 44 had myelodysplastic syndromes/myeloproliferative diseases; the remainder

Full access

Influence of Treating Facility, Provider Volume, and Patient-Sharing on Survival of Patients With Multiple Myeloma

Ashley T. Freeman, May Kuo, Lei Zhou, Justin G. Trogdon, Chris D. Baggett, Sascha A. Tuchman, Thomas C. Shea, and William A. Wood

associated with lower mortality for patients with lymphoma. 2 Similarly, patients with acute myeloid leukemia 3 or non-Hodgkin’s lymphoma 4 receiving chemotherapy at high-volume facilities have been found to have a lower mortality rate than those treated

Full access

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Peter L. Greenberg, Richard M. Stone, Aref Al-Kali, Stefan K. Barta, Rafael Bejar, John M. Bennett, Hetty Carraway, Carlos M. De Castro, H. Joachim Deeg, Amy E. DeZern, Amir T. Fathi, Olga Frankfurt, Karin Gaensler, Guillermo Garcia-Manero, Elizabeth A. Griffiths, David Head, Ruth Horsfall, Robert A. Johnson, Mark Juckett, Virginia M. Klimek, Rami Komrokji, Lisa A. Kujawski, Lori J. Maness, Margaret R. O'Donnell, Daniel A. Pollyea, Paul J. Shami, Brady L. Stein, Alison R. Walker, Peter Westervelt, Amer Zeidan, Dorothy A. Shead, and Courtney Smith

acute myeloid leukemia (AML). In the general population, the incidence rate of MDS is approximately 4.9 per 100,000 people per year. 1 MDS is rare among children/adolescents and young adults, with an incidence rate of 0.1 per 100,000 people per year in

Full access

Senior Adult Oncology, Version 2.2014

Arti Hurria, Tanya Wildes, Sarah L. Blair, Ilene S. Browner, Harvey Jay Cohen, Mollie deShazo, Efrat Dotan, Barish H. Edil, Martine Extermann, Apar Kishor P. Ganti, Holly M. Holmes, Reshma Jagsi, Mohana B. Karlekar, Nancy L. Keating, Beatriz Korc-Grodzicki, June M. McKoy, Bruno C. Medeiros, Ewa Mrozek, Tracey O’Connor, Hope S. Rugo, Randall W. Rupper, Rebecca A. Silliman, Derek L. Stirewalt, William P. Tew, Louise C. Walter, Alva B. Weir III, Mary Anne Bergman, and Hema Sundar

hospitalization in older patients with metastatic colorectal cancer. 164 Similarly, among older patients receiving induction chemotherapy for acute myeloid leukemia (AML), OS was significantly shorter for patients with impaired cognitive and physical function